Baole Wang
Impact in
-
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Cell death mechanisms and regulation
- Cancer therapeutics and mechanisms
- RNA Interference and Gene Delivery
- PI3K/AKT/mTOR signaling in cancer
Papers in
- Oncology 4
- Lung Cancer Research Studies 1
- Cancer Treatment and Pharmacology 1
-
- Cancer therapeutics and mechanisms 2
- Angiogenesis and VEGF in Cancer 1
- Cell death mechanisms and regulation 1
- Co-authors
- David J. Frost (5 shared papers)Saul H. Rosenberg (3 shared papers)Scott Ackler (3 shared papers)Anatol Oleksijew (3 shared papers)Alex R. Shoemaker (3 shared papers)Steven W. Elmore (3 shared papers)Joy Bauch (2 shared papers)Marion Refici (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (1 paper)Blood (1 paper)Energy Reports (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Baole Wang
6 papers receiving 233 citations
Peers
Comparison fields: 5 of 40
- Oncology 89
- Molecular Biology 178
- Genetics 19
- Pathology and Forensic Medicine 30
- Immunology 30
Countries citing papers authored by Baole Wang
This map shows the geographic impact of Baole Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baole Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baole Wang more than expected).
Fields of papers citing papers by Baole Wang
This network shows the impact of papers produced by Baole Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baole Wang. The network helps show where Baole Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Baole Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 165 | |
| 2 | 2008 | 65 | |
| 3 | 2020 | 3 | |
| 4 | 2006 | 2 | |
| 5 | The RTK inhibitor ABT-869, alone and in combination with paclitaxel and/or zoledronic acid, demonstrates significant reduction in the development of both osteoblastic (LuCap 23.1) and osteolytic (PC3-M-Luciferase) tumors intratibially | 2007 | 2 |
| 6 | The RTK inhibitor, ABT-869 alone or in combination with various cytotoxic therapies demonstrate significant tumor growth inhibition in orthotopic hepatocellular carcinoma, renal cell carcinoma and prostate xenografts | 2007 | 1 |
About Baole Wang
Baole Wang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Pharmacology, having authored 6 papers that have together received 238 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Lung Cancer Research Studies (1 paper), Prostate Cancer Treatment and Research (1 paper), Inflammatory mediators and NSAID effects (1 paper), Underwater Vehicles and Communication Systems (1 paper), Cell death mechanisms and regulation (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (89 citations), Molecular Biology (178 citations), Genetics (19 citations), Pathology and Forensic Medicine (30 citations) and Immunology (30 citations). Baole Wang has collaborated with scholars based in United States and China. Frequent co-authors include David J. Frost, Saul H. Rosenberg, Scott Ackler, Anatol Oleksijew, Alex R. Shoemaker, Steven W. Elmore, Joy Bauch, Marion Refici, Michael J. Mitten and Christin Tse. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Blood and Energy Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.